Wockhardt Share Price Target 2022, 2023, 2024, 2025, 2030
Wockhardt Share Price Target 2022, 2023, 2024, 2025, 2030;- Wockhardt Ltd. is a global pharmaceutical and biotechnology organization that provides affordable, high-quality medicines for a healthier world. Today, along with analyzing the complete details of Wockhardt’s business, we will also look at the future prospects of the company’s business, so that we will get an idea of which direction the company’s performance is likely to go in the coming years.
With the help of this article, we have tried to analyze Wockhardt shares using fundamental and technical analysis.
Wockhardt Share Price Target 2022
Wockhardt is India’s leading research-based and global healthcare company with a presence in pharmaceuticals, biotechnology and a chain of advanced super specialty hospitals. It is a true Indian MNC with a multi-ethnic workforce of many Wockhardt associates from many different nationalities around the world. It has many research centers and several manufacturing plants with businesses ranging from manufacturing and marketing pharmaceutical and biopharmaceuticals, active pharmaceutical ingredients (APIs) and vaccines.
The stock price target for Wockhardt will be available by the end of the financial year 2022. The initial price of Wockhardt will be around Rs 270. And the second target budget price of Wockhardt will be Rs 280.
| Year | Wockhardt Share Price Target 2022 |
|---|---|
| First Target 2022 | Rs 270 |
| Second Target 2022 | Rs 280 |
Also read:- Zydus Lifesciences Share Price Target 2022, 2023, 2024, 2025, 2030
Wockhardt Share Price Target 2023
Wockhardt is in a transforming business. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth permeates every mindset, process and technological innovation at Wockhardt today. Wockhardt has joined hands with various partners to launch products in the US market with its Illinois-based manufacturing facility set to gradually lay off all workers as part of a business restructuring in the US market.
The first target value of Wockhardt’s share for the financial year 2023 is estimated at Rs 330. And the second share price of Target of Wockhardt could offer around Rs 340.
| Year | Wockhardt Share Price Target 2023 |
|---|---|
| First Target 2023 | Rs 330 |
| Second Target 2023 | Rs 340 |
Also read:- Granules Share Price Target 2022, 2023, 2024, 2025, 2030
Wockhardt Share Price Target 2024
Wockhardt has engaged several manufacturing partners approved by the US Food and Drug Administration (USFDA) in the US market, after thorough due diligence and inspection of their facilities, to manufacture various products for sale in the US, particularly in North America. Wockhardt has initiated a global Phase III clinical trial of its new antibiotic candidate WCK 5222.
The company has completed the first study initiation visit. This is a double-blind, multicenter study of efficacy, safety, and tolerability in the treatment of hospitalized adults with complicated urinary tract infections, including acute pyelonephritis. The study will have 70 centers worldwide in 11 countries including the US, Europe, India, China and Latin America. This global study is expected to be completed in 18 months.
At this moment we are trying to predict the price of two Wockhardt which will be available in 2024. The first target price of Wockhardt is Rs 370. And the second stock price target Wockhardt could cross Rs 410.
| Year | Wockhardt Share Price Target 2024 |
|---|---|
| First Target 2024 | Rs 370 |
| Second Target 2024 | Rs 410 |
Also read:- Fortis Healthcare Share Price Target 2022, 2023, 2024, 2025, 2030
Wockhardt Share Price Target 2025
Wockhardt’s subsidiary, Wockhardt UK, has entered into a collaboration agreement with Serum Life Sciences UK, a subsidiary of the Serum Institute of India, one of the world’s largest vaccine manufacturers, to deliver a global vaccination program.
This collaboration between the Wockhardt subsidiary and Serum Life Sciences UK will help create a significant number of employment opportunities alongside the creation of a new sterile filling and finishing facility in Wrexham, North Wales (New Facility).
Wockhardt two share price targets for FY 2025. Wockhardt share price in FY 2025 will be Rs 470. And the second share price target for Wockhardt will be around Rs 490.
| Year | Wockhardt Share Price Target 2025 |
|---|---|
| First Target 2025 | Rs 470 |
| Second Target 2025 | Rs 490 |
Also read:- Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030
Wockhardt Share Price Target 2030
Wockhardt’s subsidiary, Wockhardt Bio AG, has partnered with Jiangxi Jemincare Group Company, China (Jemincare) for Wockhardt’s new proprietary antibiotic WCK 4873 in the People’s Republic of China, Hong Kong, Macau and Taiwan for the treatment of community-acquired bacterial pneumonia and others. respiratory tract infection.
Under the terms of the definitive agreement, Jemincare will be responsible for the exclusive development and commercialization of nafithromycin in selected markets. A joint steering committee is created to oversee the development and regulatory activities.
Wockhardt’s stock price target will be available by the end of the financial year 2030. Wockhardt’s first share price will be Rs 900. And the second price target on Wockhardt stock will be Rs 1000 by the end of the financial year 2030.
| Year | Wockhardt Share Price Target 2030 |
|---|---|
| First Target 2030 | Rs 900 |
| Second Target 2030 | Rs 1000 |
Also read:- Gland Pharma Share Price Target 2022, 2023, 2024, 2025, 2030
Future Prospectus of Wockhardt Share
- Wockhardt’s subsidiary, Wockhardt Bio AG, has partnered with Jiangxi Jemincare Group Company, China for Wockhardt’s new proprietary antibiotic WCK 4873 in the People’s Republic of China, Hong Kong, Macau and Taiwan for the treatment of community-acquired bacterial pneumonia and others. respiratory tract infection.
- Wockhardt’s subsidiary, Wockhardt UK, has entered into a collaboration agreement with Serum Life Sciences UK, a subsidiary of the Serum Institute of India, one of the world’s largest vaccine manufacturers, to deliver a global vaccination program.
Wockhardt Share Price Target 2022, 2023, 2024, 2025, 2030 Table
| Year | Wockhardt Share Price Target |
|---|---|
| First Target 2022 | Rs 270 |
| Second Target 2022 | Rs 280 |
| First Target 2023 | Rs 330 |
| Second Target 2023 | Rs 340 |
| First Target 2024 | Rs 370 |
| Second Target 2024 | Rs 410 |
| First Target 2025 | Rs 470 |
| Second Target 2025 | Rs 490 |
| First Target 2030 | Rs 900 |
| Second Target 2030 | Rs 1000 |
Risk of Wockhardt Share
- Wockhardt needs additional funds to realize its full potential across the industry, otherwise, Wockhardt will not be able to provide benefits or returns to its investors in the years to come.
- Wockhardt has a very high debt to the company which needs to be reduced in the coming years otherwise any sales or revenue they generate annually will be used to cover their debts.
Expert Views on Wockhardt Share
With all the features related to Wockhardt we can say that you should watch this stock for some time and I would say you need to wait sometime before investing in Wockhardt stock.
Wockhardt Share F.A.Q.
– Where is the headquarters of Wockhardt located?
The Wockhardt headquarters is located in Mumbai, India.
– Who is the current Wockhardt MD?
Murtaza Khorakiwala is the current MD of Wockhardt.
– In which business is Wockhardt involved?
Wockhardt is a global pharmaceutical and biotechnology organization engaged in the production of finished dosage forms, injectables, biopharmaceuticals, oral and topical products.
Conclusion
I hope that after reading the article Wockhardt Share Price Target 2022, 2023, 2024, 2025, 2030 you must have got a good idea what kind of performance can be seen in the growth of the Company. If you still have any question related to this article in your mind, then do not forget to tell in the comment at all. Stay tuned to Market in India for important information about this type of stock in the stock market.
Also read:-
